Modelos experimentales murinos en la esclerosis lateral amiotrófica. Puesta al día

Resumen: Introducción: La esclerosis lateral amiotrófica (ELA) es una enfermedad neurodegenerativa, progresiva y de etiología desconocida caracterizada por la degeneración de motoneuronas superiores e inferiores. Aproximadamente el 90% de los casos de ELA son esporádicos, mientras que el 10% restan...

Full description

Bibliographic Details
Published in:	Neurología
Main Authors:	L. Moreno-Jiménez, M.S. Benito-Martín, I. Sanclemente-Alamán, J.A. Matías-Guiu, F. Sancho-Bielsa, A. Canales-Aguirre, J.C. Mateos-Díaz, J. Matías-Guiu, J. Aguilar, U. Gómez-Pinedo
Format:	Article
Language:	Spanish
Published:	Elsevier España 2024-04-01
Subjects:	Amyotrophic lateral sclerosis SOD1 TDP43 FUS C9ORF72 Cerebrospinal fluid
Online Access:	http://www.sciencedirect.com/science/article/pii/S0213485321001407

Similar Items

Murine experimental models of amyotrophic lateral sclerosis: an update
by: L. Moreno-Jiménez, et al.
Published: (2024-04-01)

Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis
by: Florent Laferriere, et al.
Published: (2015-01-01)

Understanding the Role of Inflammation in ALS-FTSD: A systematic Review and Meta-analysis Investigating the Relationship between Inflammation and Amyotrophic Lateral Sclerosis and Frontotemporal Spectrum Disorder.
by: Scott Purdie, et al.
Published: (2025-01-01)

Genetic alterations of C9orf72, SOD1, TARDBP, FUS, and UBQLN2 genes in patients with Amyotrophic Lateral Sclerosis
by: Ciftci Vildan, et al.
Published: (2019-01-01)

DNA Damage, Defective DNA Repair, and Neurodegeneration in Amyotrophic Lateral Sclerosis
by: Anna Konopka, et al.
Published: (2022-04-01)

Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
by: Matthew P. Shaw, et al.
Published: (2018-11-01)

Genetics of familial amyotrophic lateral sclerosis
by: A. V. Savinova, et al.
Published: (2021-10-01)

Modeling Protein Aggregation and the Heat Shock Response in ALS iPSC-Derived Motor Neurons
by: Emily R. Seminary, et al.
Published: (2018-02-01)

The role of interferon signaling in neurodegeneration and neuropsychiatric disorders
by: Daniel W. Sirkis, et al.
Published: (2024-10-01)

FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD
by: Yuzo Fujino, et al.
Published: (2023-07-01)

Drosophila as a Model for Assessing the Function of RNA-Binding Proteins during Neurogenesis and Neurological Disease
by: Eugenia C. Olesnicky, et al.
Published: (2018-08-01)

Mislocalization, aggregation formation and defect in proteolysis in ALS
by: Atsushi Tsubota, et al.
Published: (2016-05-01)

La citotoxicidad del líquido cefalorraquídeo en la esclerosis lateral amiotrófica
by: J. Matías-Guiu, et al.
Published: (2010-07-01)

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
by: Mfon E Umoh, et al.
Published: (2017-11-01)

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration
by: Randall J. Eck, et al.
Published: (2024-01-01)

Pathophysiology, Clinical Heterogeneity, and Therapeutic Advances in Amyotrophic Lateral Sclerosis: A Comprehensive Review of Molecular Mechanisms, Diagnostic Challenges, and Multidisciplinary Management Strategies
by: María González-Sánchez, et al.
Published: (2025-04-01)

Accumulation of TDP-43 causes karyopherin-α4 pathology that characterises amyotrophic lateral sclerosis
by: Manpreet Singh Atwal, et al.
Published: (2025-07-01)

Proteins Associated with Neurodegenerative Diseases: Link to DNA Repair
by: Svetlana N. Khodyreva, et al.
Published: (2024-12-01)

CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
by: Sarah Pickles, et al.
Published: (2023-08-01)

Differences in Cerebral Glucose Metabolism in ALS Patients with and without <i>C9orf72</i> and <i>SOD1</i> Mutations
by: Joke De Vocht, et al.
Published: (2023-03-01)

Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias
by: Clémence Fournier, et al.
Published: (2018-05-01)

Gene Therapy in Amyotrophic Lateral Sclerosis
by: Ton Fang, et al.
Published: (2022-06-01)

Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?
by: Anais eAulas, et al.
Published: (2015-10-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology
by: Raquel Alsina, et al.
Published: (2024-06-01)

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
by: Guinevere F. Lourenco, et al.
Published: (2015-10-01)

Bioenergetic and Autophagic Characterization of Skin Fibroblasts from <i>C9orf72</i> Patients
by: Maria Isabel Alvarez-Mora, et al.
Published: (2022-06-01)

Novel miR-b2122 regulates several ALS-related RNA-binding proteins
by: Zachary C. E. Hawley, et al.
Published: (2017-10-01)

Copper toxicity and deficiency: the vicious cycle at the core of protein aggregation in ALS
by: Jin-Hong Min, et al.
Published: (2024-07-01)

Motor Neuron Generation from iPSCs from Identical Twins Discordant for Amyotrophic Lateral Sclerosis
by: Emily R. Seminary, et al.
Published: (2020-02-01)

Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
by: Bilal Khalil, et al.
Published: (2024-01-01)

Repeat‐associated non‐AUG translation in C9orf72‐ALS/FTD is driven by neuronal excitation and stress
by: Thomas Westergard, et al.
Published: (2019-01-01)

Enhanced insulin signalling ameliorates C9orf72 hexanucleotide repeat expansion toxicity in Drosophila
by: Magda L Atilano, et al.
Published: (2021-03-01)

The Development of C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Disorders
by: Qijie Yang, et al.
Published: (2020-09-01)

Accurate DNA methylation predictor for C9orf72 repeat expansion alleles in the pathogenic range
by: Naren Ramesh, et al.
Published: (2026-01-01)

Patterns of altered in vivo brain metabolism in patients with amyotrophic lateral sclerosis (ALS) and asymptomatic C9orf72 mutation carriers: a cross-sectional 1H and 31P magnetic resonance spectroscopic 7T imaging studyResearch in context
by: Henk-Jan Westeneng, et al.
Published: (2025-11-01)

PARP1 Activation Controls Stress Granule Assembly after Oxidative Stress and DNA Damage
by: Anastasia S. Singatulina, et al.
Published: (2022-12-01)

LINC complex alterations are a key feature of sporadic and familial ALS/FTD
by: Riccardo Sirtori, et al.
Published: (2024-04-01)

La esclerosis lateral amiotrófica (ELA)
by: JAVIER TORRES ZAFRA, et al.
Published: (2007-07-01)

La esclerosis lateral amiotrófica (ELA)
by: JAVIER TORRES ZAFRA, et al.
Published: (2007-07-01)